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ABSTRACT

Gut, Jr., Chester Preston., M.S. Department of Pharmacology and Toxicology, Boonschoft
School of Medicine, Wright State University, 2010.
Hyperbaric Oxygen in the Prevention of Carbon Monoxide Induced Delayed Neurological
Sequelae In Male Sprague-Dawley Rats (Rattus norvegicus)

In Carbon Monoxide (CO) induced Delayed Neurological Sequelae (DNS) clinical signs
develop 1 to 6 weeks after CO has cleared the body. The aim of this experiment was to
develop a model of CO induced DNS which closely mimics “real world” conditions both in
exposure and treatment. The model was challenged with hyperbaric or normobaric oxygen,
or room air. Basic behaviors were measured by Open Field test on days 1, 7, 14 post
exposure and treatment. No significant difference in behavior was observed between
exposed and control animals or between treatment groups. Histological analyses showed no
DNA or necrotic damage to the basal ganglia, cortex, or hippocampus in CO exposed
animals at time of euthanasia regardless of treatment. Data suggest variability in tolerance to
CO and development of DNS. Data also indicates that the in vivo COHb half-life is not
constant across species.
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BACKGROUND
Carbon monoxide (CO) is a simple, yet highly toxic diatomic gas. The toxicity of CO has
been known since ancient times where it was used as a means of execution, and is suspected
in the deaths of two Byzantine emperors (Lascaratos and Marketos 1998; Prockop and
Chichkova 2007). Exogenously, CO is the product of incomplete combustion of
hydrocarbons, thus, it is ubiquitous outside the body (Prockop and Chichkova 2007).
Endogenously, CO is produced by the breakdown of heme into bile pigments. (Ryter, Alam
et al. 2006) The resultant CO is then used as a vasodialator in conjunction with NO, and
may modulate long-term potentiation and neurotransmitter release (Haldane 1895; Zhuo,
Small et al. 1993; Piantadosi, Zhang et al. 1997). CO is also a signaling molecule involved
with apoptosis and inflammation (Prockop and Chichkova 2007). Despite its ubiquity, CO
is one of the most deadly toxins per capita on the planet. It has been estimated that more
than half of the fatal poisonings around the world are caused by CO (Raub, Mathieu-Nolf et
al. 2000).
Several physical characteristics of CO contribute to the deadly nature of the gas. It is
completely undetectable by humans without mechanical means. It is odorless, tasteless, and
invisible, at any concentration. The molecular weight of CO is 28 (the weighted average
molecular weight of atmospheric air at sea level is approximately 29) (Penney 2008). CO is
completely miscible in air, it will not pool within any particular area of a given space.
Although these characteristics certainly contribute to the severe toxicity of CO, it is
hemoglobin’s affinity for it that makes the gas so deadly to humans.
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Inside the mammalian body, hemoglobin has an affinity for CO between 210-240 times that
of oxygen (O2)(Haldane 1895; Allen and Root 1957; Garland and Pearce 1967; MacMillan
1977; Ginsberg 1985). Even though the resulting compound, carboxyhemoglobin (COHb)
is readily made, the CO is not as rapidly released from it, severely reducing the oxygen
carrying capacity of the blood. The half-life for COHb in humans is well established at 4 – 6
hours in normal, atmospheric air (Haldane 1895; Allen and Root 1957). This relatively long
half-life results in a prolonged O2 deficiency (hypoxia) in the higher metabolic tissues. Due
to their high metabolic rates, the two organs most affected by the resultant lack of oxygen
are the heart and brain. The tissue site of COHb formation, the lung, is relatively
transparent to CO toxicity (Penney 2008). CO also binds to myoglobin further exacerbating
hypoxia in the brain, heart, and other highly metabolic tissue (Prockop and Chichkova 2007;
Wolf, Lavonas et al. 2008). CO also causes tighter binding of O2 to oxyhemoglobin, shifting
the oxygen dissociation curve to the left, further impeding the release of the available O2 in
arterial blood (Penney 2008).
The symptoms of CO intoxication vary widely ranging from mild febrile symptoms to coma
and death (Raub, Mathieu-Nolf et al. 2000; Prockop and Chichkova 2007; Penney 2008). It
is estimated that in approximately 50% of CO intoxication cases short-term symptoms
include, but are not limited to, headache, weakness, nausea, confusion, and shortness of
breath (Prockop and Chichkova 2007). Headache occurs in 84% of reported cases of CO
intoxication (Handa and Tai 2005). It has been noted that because of the nonspecificity of
these symptoms CO intoxication is often misdiagnosed, or missed completely upon
presentation at the hospital (Raub, Mathieu-Nolf et al. 2000; Penney 2008). It is also noted
that COHb measurements taken upon arrival at the hospital do not correlate with the
symptoms or their severity (Garland and Pearce 1967; Choi, Kim et al. 1995; Thom, Taber et
2

al. 1995). It is interesting that the one symptom most commonly associate with CO
intoxication, the cherry-red coloration of the skin and cyanosis are not frequently seen
(Lapresle and Fardeau 1967).
Delayed neurological sequelae (DNS) are one of the more bizarre and insidious clinical
presentations of acute CO intoxication. This symptom is as bizarre as it is tragic. It appears
anywhere from 1 – 6 weeks after CO has cleared the body (Garland and Pearce 1967; Lee
and Marsden 1994; Choi, Kim et al. 1995). The clinical signs of DNS include, but are not
limited to, cognitive deficit, severe dementia, psychosis, Parkinsonism (shaking), and
incontinence (Garland and Pearce 1967; Lee and Marsden 1994; Choi, Kim et al. 1995;
Mimura, Harada et al. 1999). DNS occurs in 0.2-40% of those individuals who survive acute
CO intoxication (Lee and Marsden 1994; White 2008). In two thirds of these individuals
the DNS will be persistent (Raphael, Elkharrat et al. 1989; Thom, Taber et al. 1995; Weaver,
Hopkins et al. 2002).

Since DNS occurs after the blood COHb concentrations return to

baseline levels, CO induced hypoxia can be ruled out as its cause (Piantadosi, Zhang et al.
1997). Piantandosi hypothesized that DNS was due to delayed neuronal damage incurred via
mechanisms similar to those associated with ischemia (Piantadosi, Zhang et al. 1997).
Normobaric oxygen treatment (NBOT) is the standard treatment for CO intoxication, being
available at all emergency medical facilities(White 2008). NBOT lowers the half-life of
COHb from 4-6 hours to 1-1.5 hours, as Haldane first concluded in 1895 “the higher the
oxygen tension the less dependent an animal is on its red corpuscles as oxygen carriers, since
the oxygen simply dissolved in the blood becomes considerable when the oxygen tension is
high” (Haldane 1895).

This increases the dissolved oxygen in blood to 1.5 mL/dL, five

time the normal amount (Prockop and Chichkova 2007) Although commonplace, NBOT
3

has not proven itself to be effective in the prevention and/or treatment for CO induced
DNS (White 2008).
Hyperbaric oxygen treatment (HBOT) is 100% oxygen at increased pressure, usually 2 -3
atmospheres for 1 -1.5 hours (Simman 2010). Its main affect is to lower the half-life of
COHb to approximately 20 minutes (Pace, Strajman et al. 1950; Sasaki 1975). Following
Haldane’s conclusion above, HBOT increases arterial oxygen tension, and therefore
increases the dissolved oxygen to 6 mL/dL, 20 times the normal level (Prockop and
Chichkova 2007). In addition to this benefit, HBOT has been demonstrated to prevent
neutrophil adherrance to the brain microvascular endothelium, thus CO-mediated oxidative
stress, which generates abnormalities in myelin basic proteins (Thom, Bhopale et al. 2004;
Thom, Bhopale et al. 2006; Tomaszewski 2008). HBOT is the recommend treatment for
CO intoxicated patients who are unconscious, and/or have a blood COHb level > 25%,
(15% for a pregnant female) (Tibbles and Perrotta 1994; Hampson, Dunford et al. 1995;
Ernst and Zibrak 1998; Thom 2002). Despite the seemingly inherent advantages to HBOT
there is still great debate in the medical community on the effectiveness of HBOT as the sole
treatment for CO intoxication (Gibson, Davis et al. 1991; Gilmer, Kilkenny et al. 2002;
Isbister, McGettigan et al. 2003; Weaver, Valentine et al. 2007; Scheinkestel and Millar 2008).
This experiment was designed to support the theory that DNS is caused by delayed neuronal
damage in the forms of either apoptosis or necrosis after acute CO intoxication. Exposure
times and concentrations were determined based on a predictive curve COHb formation in
rats by Benignus and Annau (Figure 1) coupled with Piantadosi’s findings regarding behavior
and neuronal damage 30 days post CO intoxication (Benignus and Annau 1994; Piantadosi,
Zhang et al. 1997).
4

Figure 1: The Benignus-Annau Curve: Plots COHb% as function of time of exposure.
Small points are observed individual values, circles are CFKE predicted values. Lines are
drawn through means of observed data (Benignus and Annau 1994).
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The experiment was designed in three phases. Phase I determined the exposure time and
CO concentration. This was guided by the dosing curve generated by Benignus and Annau
(Figure 1)(Benignus and Annau 1994). This curve predicts COHb levels for various
concentrations of CO in air as a function of exposure time. Benignus and Annau developed
this predictive curve using data obtained from experiments using inbred, Long Evans rats
and we were using Sprague-Dawley rats as did Piantadosi (Benignus and Annau 1994;
Piantadosi, Zhang et al. 1997). These two differences (different strain and outbred) require
verification of the predictive model for this entire study.
The ultimate goal of this study was to provide evidence that HBOT is superior to NBOT in
the prevention of CO induced DNS. In order to do this, it was necessary to induce DNS in
a maximum number of CO exposed rats. To do this, we chose endpoints of 50-55% COHb
blood level and syncope. These two endpoints are predictors for DNS development in
humans, particularly syncope (Myers, Snyder et al. 1985; Lee and Marsden 1994; Choi, Kim
et al. 1995; Thom, Taber et al. 1995; Mimura, Harada et al. 1999; Lee, Mak et al. 2001;
Gilmer, Kilkenny et al. 2002; Weaver, Valentine et al. 2007). We postulated that these two
endpoints would produce the desired effect in the maximum number of rats surviving the
CO exposure. Phase II is the development of a viable rat behavioral model for DNS. A
thorough review of the current literature showed a wide variety in CO exposure techniques,
a lack of a standard rat model for DNS, and vague or nonexistent descriptions of visible
clinical signs of CO induce DNS in aniumals (Piantadosi, Zhang et al. 1997; Gilmer,
Kilkenny et al. 2002; Gu, Januszkiewicz et al. 2005). A measureable, repeatable, readily
observable rat model of CO in would need to be developed for this and the following phase
of this experiment. Phase II draws heavily on the work of Piantadosi. After Piantadosi,
Sprague-Dawley rats were chosen for this experiment, and neurobehavioral tests were to be
6

performed on days 1, 7, 14, 21, and 28 post exposure (Piantadosi, Zhang et al. 1997). Unlike
Piantadosi, our neurobehavioral test would be limited to Open Field tests as personnel and
equipment constraints prevented the effective use of a Radial Arm Maze for testing learning
and memory.
Phase III is designed to challenge the neurobehavioral model developed in Phase II with
room air, normobaric oxygen, or hyperbaric oxygen. Phase III employs 100% O2 at 3
atmospheres of pressure for 1 hour as described (Tibbles and Perrotta 1994; Gilmer,
Kilkenny et al. 2002; Weaver, Hopkins et al. 2002; Isbister, McGettigan et al. 2003;
Scheinkestel and Millar 2008; Tomaszewski 2008; White 2008). Phase III occurs in two sub
phases: immediate treatment or delayed treatment.
The histological regions of the brain selected for study are: the basal ganglia (exterior globus
pallidus), hippocampus (dentate gyrus), and cortex per Piantadosi (Piantadosi, Zhang et al.
1997). These are the most metabolically active areas of the brain thus most likely to be
affected by CO intoxication (Choi 1983; Ginsberg 1985; Ishimaru, Katoh et al. 1992).
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HYPOTHESES AND OBJECTIVES

Hypothesis
The administration of Hyperbaric Oxygen after Carbon Monoxide intoxication will prove
more effective in preventing delayed neurological sequelae than normobaric oxygen or room
air.
Sub Hypotheses
1) Delayed Neurological Sequelae are produced by necrosis and/or increased levels of
apoptosis in the basal ganglia, cortex, and/or hippocampus.
2) There is a therapeutic window outside of which hyperbaric oxygen is no more
effective than normobaric oxygen or room air.
Objectives
1) Establish in rat a model of DNS following CO intoxication
2) Challenge model with hyperbaric or normobaric oxygen treatment
3) Establish treatment “window”
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MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats (Charles River Laboratories, Raleigh, NC) at 250-360g body
weight were used in this study. The rats were kept in an AAALAC approved facility on a 12
hour light/dark cycle with food and water ad libitum. All rats were observed daily until
euthanization (see below). All procedures involving live animals were approved by the
WPAFB Institutional Animal Care and Use Committee (IACUC), Protocol # F-WA-20080107-A.
CO Exposure
Determination of Exposure Time at 1000 ppm CO in Air
Individual groups of rats were exposed to one time 1000 ppm CO in air (Weiler Welding,
Moraine, OH) in an exposure chamber of our own design (Reboulet, Lear et al. 2009) for a
one time exposure at 75, 90, 105, 120, or 180 minutes until a carboxyhemoglobin level of
least 50% and/or syncope (See Picture 1 ). CO concentrations were monitored in real time
with a BINOS monitor (Infincon, East Syracuse, NY). Final exposure time repeated one
time to confirm (See Figure 2).
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Determination of Exposure Time at 3000 ppm CO in Air
Individual groups of rats were exposed to one time, 3000 ppm CO in air (Weiler Welding,
Moraine, OH) in an exposure chamber of our own design (Reboulet, Lear et al. 2009) for a
one time exposure at 135 minutes until a carboxyhemoglobin level of least 50% and/or

10

Picture 1: Photo and Schematic of the exposure chamber. Note how exhalents are drawn
out through the bottom plenum. Chamber is under slight negative pressure. It provides 15
atmospheric exchanges per minute (Reboulet, Lear et al. 2009).
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syncope (see Results). CO concentrations were monitored in real time with a Model 880A
monitor (Rosemount Analytical, Solon, OH). Final exposure time was repeated to confirm
(See Figure 2).
Development of CO Induced DNS Neurobehavioral Model
Rats were exposed to CO in air at either 1000 or 3000 ppm for times determined above. Rats
were returned to their cages to recover in ambient room air. Control animals were placed in
the exposure chamber for the same time period in only room air. All CO exposed rats were
observed for mortality for 1 hour post exposure, and living animals were returned to the
Vivarium. All rats had access to food and water ad libitum post time in the exposure
chamber. At 24 hrs, 7, 14, 21, and 28 days post exposure, all rats (control and exposed) were
individually studied in PAS-OF chambers (San Diego Instruments, San Diego, CA), where
their movements (active time, number of rears, distance traveled) measured via light beam
breaks (See Picture 2). The placement of the rats in the PAS chambers was designed so that
no rat would be in the same cage twice or next to the same rat or rats twice. The duration of
the testing was 30 minutes while their movements were recorded using PAS Recorder
software (v.2.07.101 San Diego Instruments, San Diego, CA). The spacing of testing days
was done to prevent habituation. A random selection of rats, both control and CO exposed,
was video recorded with a Handycam HDR-SR11 digital camcorder (SONY, Japan) to
capture any observable clinical signs of sequelae in CO exposed rats. All neurobehavioral
testing was done in low light conditions with 65 decibels background, white noise was
generated by a TX-903 tuner amplifier (Onkyo, Japan). This was done to control
environmental conditions in the testing room as tightly as possible.
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Picture 2: The PAS Open Field testing chambers. Movements are measure by the rats
breaking light beams crisscrossing the chamber.
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Figure 2: Master plan for optimization of CO exposure animal usage. Actual animal usage
did not reflect what is pictured here. This general model was used for all CO exposure
optimizations.
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Exposure to CO Prior to Treatment in Hyperbaric Chamber
CO Exposed Rats
Rats were exposed to 3000 ppm CO in air for 75 minutes (not including a 20 minute ramp
up time to 3000 ppm CO, and a 5 minute chamber evacuation time). After the CO was
evacuated the rats were removed from the exposure chamber, and placed into the hyperbaric
chamber. For the “immediate treatment” subgroup, the rats were placed in to the hyperbaric
chamber immediately after the CO had been evacuated from the exposure chamber. For the
“delayed treatment” subgroup, the rats were returned to their home cages for 4 hours.
After four hours in their home cage the rats were returned to the dosing cages and placed
into the hyperbaric chamber. During the 4 hours in their home cages the rats with food and
water ad libitum (See Figure 3).
Control Rats
Control rats treated as described above without exposure to CO. These rats spent the same
time in the exposure chamber, but were only exposed to room air.
One rat was kept completely naïve. It did not spend time in either the exposure chamber or
the hyperbaric chamber. It was not exposed to CO or O2. This rat’s brain tissue served as
the control tissue for the TUNEL and H&E analyses.

15

Figure 3: Master plan for treatment subgroups. This model was used for both immediate
and delayed treatment procedures. This chart also shows the division of control and
exposed rats.

Treatment of Rats in Hyperbaric Chamber
16

Room Air Treatment Sub Group
All rats(control or CO exposed) were placed in the hyperbaric chamber (Type II Animal
Hyperbaric Chamber No. 33629 – Dixie Mfg. Co., Baltimore, MD) for 120 minutes and
treated with room air at ambient temperature and pressure.
Hyperbaric Oxygen Treatment Sub Group
All rats (control and CO exposed) were placed into the hyperbaric chamber (Type II Animal
Hyperbaric Chamber No. 33629 – Dixie Mfg. Co., Baltimore, MD) and treated with 3
atmospheres of 100% O2 (See Picture 3) . The total time the rat spent in the hyperbaric
chamber was 120 minutes. This time included 20 minutes pressurization and atmosphere
change out to 100% O2(99.999% Research Grade - Weiler Welding, Moraine, OH); 60
minutes at 3 atmospheres with 100% O2; and 40 minutes decompression and venting of O2
in chamber to room air. Oxygen levels were monitored using a Percent Oxygen Analyzer
(Teledyne Analytical Instruments, City of Industry, CA).
Normobaric Oxygen Treatment Sub Group
All rats (control and CO exposed) were placed in the hyperbaric chamber and treated with
100% O2 for a total of 120 minutes. In order to mimic the 100% O2 exposure time of the
hyperbaric treatment, the time included 5 minutes atmosphere change out to 100% O2 and 5
minutes of venting out the 100% O2 in the chamber to room air (20% O2). Oxygen levels
were monitored as above.
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Picture 3: The hyperbaric chamber. It is design to provide up to 1500 psi. The experiment
used 44.1 psi (3 ATA).

18

All rats, regardless of treatment sub group, were observed periodically for signs of stress or
discomfort while in the hyperbaric chamber. After completion of treatment, the rats were
removed from the chamber and returned to their home cages with food and water ad libitum.
The rats were observed for 1 hour post treatment before being returned to the vivarium.
Post CO Exposure and Treatment Neurobehavioral Testing
All rats (control and CO exposed) were individually placed in PAS-OF boxes for 30 minutes
as described earlier at: 24 hours, 7, and 14 days post exposure. Their movements were
recorded as described. After neurobehavioral testing on day 14, the rats were anesthetized
and euthanized. Their brains were harvested, processed and preserved as described.
Anesthesia, Blood Work, and Euthanasia
All rats were anesthetized prior to blood sampling and euthanasia with an intraperitoneal
injection of 0.5 ml of sodium pentobarbital solution (Nembutol®, Ovation Pharmaceuticals,
Deerfield, IL) using a LO-DOSE® U-100 insulin syringe with a 28 G, ½ inch needle (BD,
Franklin Lakes, NJ). Invasive procedures were performed only after rats were no longer
responsive to toe pinch.
Blood was drawn via heart stick with a 3 mL syringe with an 18G 1 ½ in needle (BD,
Franklin Lakes, NJ). Blood was analyzed for HbCO% with an IL-682 COOximeter
(Instrumentation Laboratories, Bedford, MA) Rats were euthanized immediately post blood
draw via rapid decapitation.
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Preparation and Preservation of Brain Tissue
Brains were removed from rats after decapitation. The brains were cut coronally at Bregma -6.00 mm and -2.04 mm to produce brain sections containing either the hippocampus or the
basal ganglia. The posterior section containing the cerebellum was discarded. The desired
section were then placed individually to cryomolds (Peel-A-Way Embedding Molds, Ted
Pella, Redding, CA) with sufficient tissue freezing medium (TFM, Fisher Scientific,
Pittsburgh, PA)to cover. Brain sections were placed in a freezer and frozen to -20oC. After
24 hours, frozen cubes were transferred to zip top freezer bags to prevent drying.
Histology
Tissue slices of the hippocampus and basal ganglia were made to a thickness of 7.5 m on
an OTF 5000 Crytostat (Bright Instrument Co. Ltd, Cambridgeshire, UK). Six slides of each
brain section were prepared with three serial slices per slide.
Tissue slides were preserved in 4% paraformaldehyde in PBS for 20 minutes, rinsed in PBS,
allowed to air dry, and returned to -20oC
Hemotoxylin and Eosin Staining
H&E staining was performed in an automatic DRS-601 Sakura Diversified Stainer (SakuraFineTek, Torrence, CA) per established methods. Slides were cover slipped using a Sakura
Tissue Tek Film (Sakura FineTek, Torrence, CA).
Terminal Deoxynucleotidyl Tranferase dUTP Nick End Labeling (TUNEL)
TUNEL assay was performed on 7.5 m thick cryopreserved brain tissue slices using the In
Situ Cell Death Detection Kit, Fluorescein or TMR (Roche, Indianapolis, IN). The
20

manufacturer’s assay protocol was followed with the following exceptions to optimize the
procedure. All post fixation incubations were carried out at 37oC, permeablization was
performed for 30 minutes, and the positive control incubation was performed for 15
minutes. The permeablization solution employed a 0.2% Triton X-100 solution in 1X PBS
buffered with 0.1% sodium citrate. TUNEL labeled slides were treated with Prolong Gold
Antifade (Invitrogen, Eugene, OR) and cover slipped with Fisherfinest Premium Cover
Glass (Fisher Scientific, Pittsburgh, PA).
Image Capture
H&E
Tissue slices were viewed using a MI6000B microscope (Leica Microsystems (Switzerland)
Limited CMS GmbH) with a 10X objective under phase contrast settings. Images were
taken with a DFC300FX camera (Leica Microsystems (Switzerland) Limited CMS GmbH)
and processed with Leica Application Suite software (v.2.4.0R1[Build 795] Leica
Microsystems (Switzerland) Limited CMS GmbH).
TUNEL
Tissue slices were viewed using a BX51 microscope (Olympus America, Center Valley, PA)
with a 20X objective under the fluoroscein thiocyanate (FITC) filter. TUNEL images were
taken with a Qicam Fast 1394 camera (Quantitative Imaging Corp, San Francisco, CA) and
processed with QCapture software (v.2.90.1, Quantitative Imaging Corp, San Francisco,
CA).
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STATISTICS
COHb %
All measured values of COHb % were input into Graphpad Prism v5.03 where mean values
were calculated and compared using a two tailed, t-test with 99% confidence levels. P values
less than 0.05 were accepted as significant.
Neurobehavioral Data
All data generated from the PAS-OF system was uploaded into Microsoft Excel 2007, were
mean, standard deviation, and standard error of the mean were calculated. These values
were uploaded into Graphpad Prism v5.0 for graphing.
Comparison and evaluation of the neurobehavioral data was performed by Maj David
Kaziska, PhD of AFIT (Air Force Institute of Technology, WPAFB, OH). His explanation
of these very complicated calculations is as follows:
Repeated Measures Analysis
The data was studied using a repeated measures analysis at a level of significance of α = .05.
(Footnote: general reference is Kutner, Nachtsheim, Neter, & Li, Applied Linear Statistical
Models, 5th Edition). For each of the four response variables, a repeated-measures ANOVA
model was fit in JMP 8 software with the factors treatment, timing of the treatment
(immediate or delayed), day (the measurements were taken on three days, and the days were
a week apart), and group (exposed or control), and two and three way interactions of these
factors. Additionally, the factor of “Animal” was evaluated as a nested factor within each
Group. Final models were fit for each response variable using a backward elimination in
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which insignificant factors were removed. The hierarchical model convention under which
main effects were retained for significant interactions was followed.
Results and Interpretation
The Fixed Effects Tests indicate factors which are significant, factors in that output whose
p-values are less than α = .05 are the significant factors. In addition, the nested factor
“Animal” is significant in each of the models based on the large value of the displayed log
likelihood (the p value is not displayed for this output but this p is zero to many decimal
places).
Post Hoc Analysis
Post hoc analysis was performed using Tukey’s multiple comparisons. The Tukey method
was chosen because it is a robust analysis, not sensitive to violations of normality.
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RESULTS
Determination Of CO Exposure Time
1000 ppm
Dosing time at 1000 ppm CO in air was determined to be 180 minutes, not including 20
minute “ramp up” and 5 minutes chamber evacuation. This was made after 8 separate
exposures on 8 separate groups at 75, 90, 105, 120 and 180 minutes. Two exposures on two
separate groups were done at 120 and 180 minutes (see Table 1 ).
3000 ppm
Dosing time at 3000 ppm CO in air was determined to be 135 minutes, not including 20
minute “ramp up” and 5 minutes chamber evacuation. This was made after two separate
exposures at 90 and 135 minutes on two separate groups(see Table 2).

Lot #
R12
R12
R12
R12
R13
R13
R14
R14

N
2
2
2
4
2
7
2
4

CO Dose (ppm)
1000
1000
1000
1000
1000
1000
1000
1000

Duration (min)
75
90
105
120
120
120
180
180

Avg COHb%
43.3
47.6
48.9
46.8
48.5
51.6*
51.5
46.8

Date
12/1/2008
12/2/2008
12/2/2008
12/5/2008
12/22/2008
12/22/2008
1/27/2009
1/27/2009

* COHb measured individually over time
Table 1: Animal usage for1000 ppm CO exposure optimization

Lot #

N

CO Dose (ppm)

Duration (min)

Avg COHb %

Date

R20
R20

4
3

3000 ppm
3000 ppm

90
135

*
55.4

4/6/2009
4/7/2009

* COHb measured individually over time
Table 2: Animal usage for 3000 ppm CO exposure optimization
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COHb % vs Time of Exposure
(1000 ppm CO)
52

COHb %

50
n=1

48
46

n=3

44
42
60

75

n=3

90 105 120 135 150 165 180 195

Time (min)
Figure 4: Graph showing plateau of COHb formation as a function of exposure time at
1000 ppm CO.
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Determination of COHb Half-Life
1000 ppm
COHb half-life was determined by measuring the COHb percentages in individual rats at 0,
120, and 240 minutes post exposure to 1000 ppm CO for 120 minutes (exposure time does
not include 20 minute “ramp up” and 5 minutes chamber evacuation)(Figure 4).
3000 ppm
COHb half-life was determined by measuring the COHb percentages in individual rats at 0,
60, 120, and 180 minutes post exposure to 3000 ppm CO for 90 minutes (exposure time
does not include 20 minute “ramp up” and 5 minutes chamber evacuation)(See Figure 4).

26

60

COHb %

n=3

COHb % vs Time
Post Exposure
(1000 ppm)

40

20

0

0

n=1

n=3

120

240

Time (min)
A

COHb%

60

n=1

COHb % vs Time
Post Exposure
(3000 ppm)

40

n=1

20

n=1
n=1

0
B

0

60

120

180

Time (min)
Figure 5: Results of COHb measurement post CO exposure at 1000 ppm (A) and
3000 ppm CO (B). The 1000 ppm exposure was for 120 minutes. The 3000 ppm exposure
was for 90 minutes. Note similarities in COHb half-life regardless of concentration. The
number of rats used for each time point is indicated. One COHb reading was taken per rat.
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DNS Neurobehavioral Model
1000 ppm
After exposing rats (n=16) to 1000 ppm CO in Air as described above, neurobehavioral
testing yielded no statistically significant differences between control (n=8) rats and CO
exposed rats at any time point. No fatalities resulted from this exposure (See Figure 5).
3000 ppm
After exposing rats (n=16) to 3000 ppm CO as described above, neurobehavioral testing
yielded statistically significant differences between control (n=8) rats and CO exposed rats
(n=12). The greatest difference was on day 14 post exposure (See Figure 6).
The protocol was modified to reflect this data. The neurobehavioral testing was shortened
to 14 days post exposure.
Four rats (25%) died in the final 10 minutes of CO exposure. The COHb level was
measured as described for the deceased rats (n=4) at 71.4 + 0.7 %.
Dosing Modifications
It had been determined that CO exposure at 3000 ppm would last 135 minutes. When this
was attempted, all the rats (n=16) died after only 120 minute exposure. All remaining rats
(N=49) were resorted into three groups of 16 (control n=6, CO exposed n=10). The
endpoint for the exposure was set at 25% mortality (the only endpoint we could use from
the previous data (see above). Treatment options were kept as originally described. Both
Vivarium staff and Charles River Laboratories, confirmed that this lot of animals were
indeed outbred, Sprague-Dawley rats. Charles River Laboratories also confirmed these rats
had come from the same breeding location as the rats used in the original 3000 ppm CO
exposure time determination (see Methods and Materials). All equipment and gas was
checked and found to be within specs.
Exposure duration was determined to be 75 minutes based on 25% mortality for all three
treatment groups (room air, 100% hyperbaric oxygen, and 100% normobaric oxygen). All
surviving rats were treated per the designated groups immediately prior to exposure as
described.
This 75 minute CO exposure time would also be used for the “delayed treatment” phase of
this experiment.
Treatment
No rats died during any treatment option in the hyperbaric chamber. If a rat survived the
CO exposure then it survived through to the end of the experiment, without exception.
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Neurobehavioral Testing Post Exposure and Treatment
No significant differences were found in the neurobehavioral data. This includes differences
between control and CO exposed animals within treatment groups, and/or between
treatment groups or sub groups (See Figures 7- 12).
Histology Post CO Exposure and/or Treatment
TUNEL
3000 ppm
No apoptosis was observed in the brain tissue sections of control or CO exposed rats at the
time of sacrifice (15 days post exposure)(See Pictures 4-9).
H&E
3000 ppm Exposure
No eosinic neurons (necrosis) were observed in any of the brain tissue samples of the
exposed and/or treated rats at the time of sacrifice (15 days post exposure) (See Pictures 1015 ).
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Figure 6: Neurobehavioral data from the 180 minute exposure at 1000 ppm CO. This
exposure did not produce significant neurobehavioral differences (p<.05) between control
and CO exposed rats. Values expressed as mean + SEM.
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Figure 7: Neurobehavioral data from the 135 minute exposure at 3000 ppm CO. This
exposure did produce significant neurobehavioral differences (p<.05) between control and
CO exposed rats. Values expressed as mean + SEM. Differences peaked (p=0.019) at 14
days.
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Figure 8: Neurobehavioral data from the 75 minute exposure at 3000 ppm CO with room
air treatment immediately following. This exposure/treatment did not produce significant
neurobehavioral differences (p<.05) between control and CO exposed rats. Values
expressed as mean + SEM.
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Figure 9: Neurobehavioral data from the 75 minute exposure at 3000 ppm CO with 60
minutes 100% HBOT immediately following. This exposure/treatment did not produce
significant neurobehavioral differences (p<.05) between control and CO exposed rats.
Values expressed as mean + SEM.
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Figure 10: Neurobehavioral data from the 75 minute exposure at 3000 ppm CO with 120
minutes 100% NBOT immediately following. This exposure/treatment did not produce
significant neurobehavioral differences (p<.05) between control and CO exposed rats.
Values expressed as mean + SEM.
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Figure 11: Neurobehavioral data from the 75 minute exposure at 3000 ppm CO with room
air treatment after a 4 hour delay post exposure. This exposure/treatment did not produce
significant neurobehavioral differences (p<.05) between control and CO exposed rats.
Values expressed as mean + SEM.
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Figure 12: Neurobehavioral data from the 75 minute exposure at 3000 ppm CO with 60
minutes 100% HBOT after a 4 hour delay post exposure. This exposure/treatment did not
produce significant neurobehavioral differences (p<.05) between control and CO exposed
rats. Values expressed as mean + SEM.
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Figure 13: Neurobehavioral data from the 75 minute exposure at 3000 ppm CO with 120
minutes of 100% NBOT after a 4 hour delay post exposure. This exposure/treatment did
not produce significant neurobehavioral differences (p<.05) between control and CO
exposed rats. Values expressed as mean + SEM.
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A – Positive Control (Naïve Rat)

B – Negative Control (Naïve Rat)

C – Control Cortex

D – CO exposed Cortex

E – Control Basla Ganglia (EGP)

F – CO exposed Basal Ganglia (EGP)

G – Control Hippocampus

H- CO exposed Hippocampus

Picture 4: TUNEL Assay results on brain tissue for control and CO exposed rats treated
immediately with room air. There are no apoptotic nuclei in either CO exposed or control
rats. If damage due to CO exposure would have occurred it would have been in these rats.
(20X Magnification)
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A – Positive Control (Naïve Rat)

B – Negative Control (Naïve Rat)

C – Control Cortex

D – CO Exposed Cortex

E – Control Basal Ganglia (EGP)

F – CO exposed Basal Ganglia (EGP)

G – Control Hippocampus

H – Co Exposed Hippocampus

Picture 5 : TUNEL Assay results on brain tissue slices of control and CO exposed rats
treated immediately with 100% hyperbaric oxygen treatment (HBOT). There are no
apoptotic nuclei in either CO exposed or control rats. (20X Magnification)
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A – Positive Control (Naïve Rat)

B – Negative Control (Naïve Rat)

C – Control Cortex

D – CO Exposed Cortex

E – Control Basal Ganglia (EGP)

F – CO exposed Basal Ganglia (EGP)

G – Control Hippocampus

H – CO exposed Hippocampus

Picture 6: TUNEL Assay results on brain tissue slices of control and CO exposed rats
receive 100% normobaric oxygen treatment (NBOT) immediately post exposure. No
apoptotic nuclei are present regardless of exposure or treatment. (20X Magnification)
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A – Positive Control (Naïve Rat)

B – Negative Control (Naïve Rat)

C – Control Cortex

D – CO exposed Cortex

E – Control Basal Ganglia (EGP)

F – CO exposed Cortex (EGP)

G – Control Hippocampus

H – CO exposed Hippocampus

Picture 7: TUNEL Assay results on brain tissue slices for rats treated with room air 4 hours
post exposure to room air or CO. The results are the same for the animals treated
immediately with room air. No apoptotic nuclei are present regardless of CO exposure.
(20X Magnification)
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A – Positive Control (Naïve Rat)

B – Negative Control (Naïve Rat)

C – Control Cortex

D – CO Exposed Cortex

E – Control Basal Ganglia (EGP)

F – CO Exposed Basal Ganglia (EGP)

G – Control Hippocampus

H – Co Exposed Hippocampus

Picture 8: TUNEL Assay results on brain tissue slices for control and CO exposed rats
receiving HBOT 4 hours post exposure to room air or CO. No apoptotic nuclei detected
regardless of exposure or treatment. (20X Magnification)
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A – Positive Control (Naïve Rat)

B – Negative Control (Naïve Rat)

C – Control Cortex

D – CO Exposed Cortex

E – Control Basal Ganglia (EGP)

F – CO Exposed Basal Ganglia (EGP)

G – Control Hippocampus

H – CO Exposed Hippocampus

Picture 9: TUNEL Assay results on brain tissue slices for control and CO exposed rats
receiving NBOT 4 hours post exposure to room air or CO. No apoptotic nuclei detected
regardless of exposure or treatment. (20X Magnification)
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A – Control Cortex

B – CO Exposed Cortex

C – Control Basal Ganglia (EGP)

D – CO Exposed Basal Ganglia (EGP)

E – Control Hippocampus

F – CO Exposed Hippocampus

Picture 10: H&E stains on brain tissue of control and CO exposed rats. These rats were
treated with room air immediately post exposure to room air or CO. No necrotic cells
detected regardless of exposure. Theses picture were taken with an Olympus microscope
(see Materials and Methods) at 10X Maginification.
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A – Control Cortex

B- CO Exposed Cortex

C – Control Basal Ganglia (EGP)

D – CO Exposed Basal Ganglia (EGP)

E – Control Hippocampus

F – CO Exposed Hippocampus

Picture 11: H&E stains on brain tissue of control and CO exposed rats. These rats were
treated with HBOT immediately post exposure to room air or CO. No necrotic cells
detected regardless of exposure or treatment. (10X Magnification)
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A – Control Cortex

B - CO Exposed Cortex

C – Control Basal Ganglia (EGP)

D – CO Exposed Basal Ganglia (EGP)

E – Control Hippocampus

F – CO Exposed Hippocampus

Picture 12: H&E stains on brain tissue of control and CO exposed rats. These rats were
treated with room air immediately post exposure to room air or CO. No necrotic cells
detected regardless of exposure or treatment. (10x Magnification)
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A – Control Cortex

B – CO Exposed Cortex

C – Control Basal Ganglia (EGP)

D – CO Exposed Basal Ganglia (EGP)

E – Control Hippocampus

F – CO Exposed Hippocampus

Picture 13: H&E stains on brain tissue of control and CO exposed rats. These rats were
treated with room air i4 hours post exposure to room air or CO. No necrotic cells detected
regardless of exposure or treatment. (10X Magnification)
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A – Control Cortex

B – CO Exposed Cortex

C – Control Basal Ganglia (EGP)

D – CO Exposed Basal Ganglia (EGP)

E – Control Hippocampus

F – CO Exposed Hippocampus

Picture 14: H&E stains on brain tissue of control and CO exposed rats. These rats were
treated with HBOT 4 hours post exposure to room air or CO. No necrotic cells detected
regardless of exposure or treatment. (10X Magnification)
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A – Control Cortex

B – CO Exposed Cortex

C – Control Basal Ganglia (EGP)

D – CO Exposed Basal Ganglia (EGP)

E – Control Hippocampus

F – CO Exposed Hippocampus

Picture 15: H&E stains on brain tissue of control and CO exposed rats. These rats were
treated with NBOT 4 hours post exposure to room air or CO. No necrotic cells detected
regardless of exposure or treatment. (10X Magnification)
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DISCUSSION
The main objective of this study was to test the efficacy of hyperbaric oxygen treatment in
preventing CO induced DNS. Specifically, we asked the following questions: 1) What are
the observable clinical signs (both physical and neurobehavioral) of CO induced DNS in the
Sprague-Dawley rat; 2) Is CO induced DNS due to apoptosis, necrosis, or a combination of
the two; and 3) Is there a treatment “window” beyond which oxygen treatment of any kind
is no longer an effective preventative measure for CO induced DNS? In order to answer
these questions, the following methods were emploiyed: 1) Optimization of CO exposure to
favor the development of CO induced DNS; 2) Development of a reproducible rat
neurobehavioral model for CO induced DNS; 3) A challenge to the neurobehavioral model
with room air; normobaric oxygen, and hyperbaric oxygen treatments both immediately after
CO exposure, and 4 hours post CO exposure; 4) TUNEL analysis on brain tissue slices of
the basal ganglia, cortex, and hippocampus to detect apoptosis; and 5) H & E staining on
brain tissue slices of the basal ganglia, cortex, and hippocampus to detect necrosis.
Design of Exposure Chamber
This experiment was designed after the work done by Piantadosi (Piantadosi, Zhang et al.
1997). The final CO exposure level of 3000 ppm CO, the neurobehavioral testing time
points, rat strain, and areas of the brain studied were all inspired by that work (Piantadosi,
Zhang et al. 1997). The key differences were in the neurobehavioral tests performed, and
the delivery of CO to the rats. Piantadosi used a “bolus” exposure method. This CO
delivery method was essentially a large plastic bag where the atmosphere was forced out, and
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then a dose of 40000 ppm CO was delivered to the rats causing them to lose consciousness
(Piantadosi, Zhang et al. 1997). This experiment was designed from the beginning to closely
resemble “real world” conditions where a somewhat steady concentration of CO would be
delivered over time. The exposure chamber was designed with this in mind. The CO was
mixed with atmospheric air in an upper plenum, and drawn downwards into a lower plenum
where it was exhausted from the chamber. This kept the CO concentration within the
chamber constant, and it removed any exhalants, particularly CO2, from the rats (Reboulet,
Lear et al. 2009).
Optimization of CO Exposure at 1000 ppm
This phase of the experiment began under the following assumptions: 1) The “BenignusAnnau” COHb formation curve was accurate across rat strains; and 2) The half-life of
COHb in mammalian systems is 4-6 hours as demonstrated in humans (Haldane 1895; Allen
and Root 1957; Benignus and Annau 1994). According to Benignus and Annau, the rats
should have reached a COHb level of at least 50% after 1 hour of exposure at 1000 ppm CO
in air (Benignus 1994). The rats were expected to achieve syncope as well (Piantadosi,
Zhang et al. 1997; Gilmer, Kilkenny et al. 2002). The results of the optimization exposures
at 1000 ppm CO appeared to conflict both these assumptions. Our first exposure at 1000
ppm CO lasted for 75 minutes and produced a COHb level of 43.3%. The rats remained
conscious the entire time and showed no obvious sign of lethargy when removed from the
exposure chamber. Increases in exposure time did not always correlate to increased levels of
COHb, although that was the overall trend (See Results, Table ). Syncope was not achieved
at any exposure time, nor was an average COHb level above 50% measured. A direct
correlation between exposure time and COHb level was expected as was syncope.
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Possible explanations for these observations included: 1) weight differences in the rats, 2)
unequal distribution of CO in the exposure chamber, 3) genetic differences in the out bred
rats. There were no observed correlations between COHb levels and body weight. The
exposure had been characterized for uniform distribution of CO, so an insufficient or
uneven exposure to was ruled out (Reboulet, Lear et al. 2009). The rats were out bred to
mimic the genetic variability seen in human populations, so perhaps this was the reason for
the difference. Further review of the experimental data compared to the Benignus-Annau
curve revealed that what we were observing was exactly what was predicted by Benignus and
Annau. After approximately 1 hour of exposure to 1000 ppm CO the rats were reaching a
“steady state” plateau. However, COHb levels of approximately 55% should have been
obtained per the curve(Benignus and Annau 1994). It was hypothesized that the observed
COHb levels did not correlated with those predicted were 1) the rats being out bred, and 2)
Beningus’ data was generated with Long-Evans rats, so perhaps there is a small difference in
CO tolerance between the strains (Benignus and Annau 1994). It was also hypothesized that
the rats might be eliminating the COHb more quickly than expected. This hypothesis was
considered remote at best, as we had found no current peer reviewed literature documenting
this.
To test the hypothesis that COHb was being eliminated by the rats more quickly than
expected, seven naive rats were exposed to 1000 ppm CO in air for 120 minutes. These rats
were allowed to recover from the exposure in room air for 120 minutes before measuring
their COHb level. The exposed rats were expected to have a COHb level of approximately
38%. This was assuming the COHb half-life was 4- 6 hours, and the animals had achieved a
COHb level of approximately 50% as data from previous 120 minute exposures at 1000
ppm CO indicated. The average COHb level was 5.8% (n=2) 120 post exposure. At 240
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minutes post exposure, COHb levels were less than the control rats (control = 4.1% COHb,
exposed = 3.0 %). This result was completely unexpected. Possible reasons for these results
included: equipment failure, and/or the CO was delivered mixed with 100% O2 , not
atmospheric air as requested. Thorough inspection and testing of all the equipment (CO
monitor, COOximeter, exposure chamber) revealed no malfunctions.

The CO supplier

was contacted and they provided documentation verifying that they had 10% CO in
atmospheric air as requested. Testing of the CO gas in did not show more than 20% O2.
This data places the COHb half-life at approximately 20-45 minutes in vivo for the Sprague
Dawley rat! A further current literature search yields only two sources documenting the in
vivo COHb half-life in rats. The first by Kimmel, Carpenter et al. indicates an in vivo COHb
half-life in male, F-334 rats at approximately 2 hours. The in vivo COHb concentrations
were measured for only one hour post exposure to 500 ppm Co in air for 1 hour (Kimmel,
Carpenter et al. 1999). The second, by Andersen et al., exploring the kinetics of
dichloromethane (CO is a metabolite of dichloromethane), shows an in vivo COHb half-life
of approximately 20 minutes (Andersen, Clewell et al. 1991)(See Figure 13). This was after

53

Figure 14: Blood COHb concentrations vs time in humans(a) and male, F334 rats (b).
Human dat was produced by RD Stewart and refenced in by Andersen et al. (Stewart 1975;
Andersen, Clewell et al. 1991). This graph clearly show the in vivo,20 minute half-life of
COHb in F334 rats vs the established 4-6 hour COHb half-life in humans.
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an exposure of 500 ppm CO for 2 hours (Andersen, Clewell et al. 1991). Review of the raw
data from the Andersen paper reveals an unpublished calculation of rat COHb half-life at 26
minutes (Andersen, Clewell et al. 1991). A possible reason for this rapid elimination of
COHb from the rat is the rate of respiration. A typical rat has respiratory rate of 70-115
breaths per minute (Sharp and Regina 1998). By comparison a normal human respiratory
rate is about 12 breaths per minute (Guyton and Hall 2000).
Despite this very surprising result, the study continued as originally planned, as CO induced
DNS develops long after COHb levels return to baseline (1.0-3.0%).
A final pilot exposure for 180 minutes at 1000 ppm CO was performed. The first exposure
for 180 minutes yielded an average COHb level of 51.5 % (n=2). Still, the rats remained
conscious during the entire exposure and showed no obvious signs of lethargy when
removed from the exposure chamber. This exposure procedure was repeated on the
remaining rats from this lot (n=4) obtaining an average COHb of 46.8%. This lower COHb
result was attributed it to the recently discovered short half life. If the time for the CO to
clear the exposure chamber (5 min) and for the anesthesia to take affect before the heart
stick was performed (5 minutes) is factored in, COHb levels are in easily in excess of 50%.
Although the rats did not reach syncope, an indicator of DNS development in humans, it
was postulated that a 180 minute exposure would be sufficient to generate the predicted,
observable neurobehavioral effects (Choi 1983; Myers, Snyder et al. 1985; Lee and Marsden
1994; Thom, Taber et al. 1995; Mimura, Harada et al. 1999; Lee, Mak et al. 2001; Gilmer,
Kilkenny et al. 2002; Weaver, Valentine et al. 2007).
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DNS Rat Model Development at 1000 ppm CO
No standard animal model for CO induced DNS exists. In fact most major studies on CO
intoxication have been performed on different strains of rat.

All rats survived the 180

minute exposure at 1000 ppm CO in air. As expected the animals neither reached syncope,
nor were lethargic when removed from the exposure chamber. We observed the rats closely
for any adverse affect of the CO exposure, but their behavior post exposure was
indistinguishable from the control animals. Because there is no clear description of the
clinical signs of, or FOB for DNS in rats in the literature, both control and CO exposed rats
were video recorded during the open field neurobehavioral testing. This was to capture clear
physical signs of the CO induced DNS. The symptoms of CO induced DNS are readily
apparent in humans (shaking, disorientation, incontinence, etc.), and it was assumed that rats
would exhibit the same clinical signs (Garland and Pearce 1967; Lee and Marsden 1994;
Choi, Kim et al. 1995; Mimura, Harada et al. 1999). Thus there would be a reference source
for an FOB for the clinical signs of CO induced DNS in male, Sprague-Dawley rats for
future studies.
The following assumptions were made regarding the development of our DNS model: 1) the
rats would all develop DNS at the same time, and 2) an exposure time of 180 minutes would
be sufficient induce DNS. These were broad assumptions. The litraure suggests that if
DNS develops, their appearance/manifestation depends on the individual (Garland and
Pearce 1967; Choi 1983; Ginsberg 1985; Gibson, Davis et al. 1991; Benignus 1994;
Piantadosi, Zhang et al. 1997; Ernst and Zibrak 1998; Lee, Mak et al. 2001; Raub and
Benignus 2002; Brunssen, Morgan et al. 2003; Scheinkestel, Jones et al. 2004; Handa and Tai
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2005; Prockop and Chichkova 2007; Weaver, Valentine et al. 2007; Hampson and Hauff
2008) .
As documented in the results section, the 180 minute exposure to 1000 ppm CO in air
yielded no observable, measurable neurobehavioral sings of DNS. The protocol was
modified to increase the concentration of CO to 3000 ppm
Optimization of CO Exposure at 3000 ppm
Given the COHb half-life data from the 1000 ppm exposure, the COHb levels in the CO
exposed rats at 60 minute time points post exposure. Prior to the increase in CO
concentration, all equipment was rechecked and calibrated, ensuring that the CO was equally
distributed within the exposure chamber. As there was only one literature source for the
half-life of CO in rats(Andersen, Clewell et al. 1991), it was hypothesized that CO
concentration would have an effect on rate COHb elimination. Also should the data be
similar to what was observed at 1000 ppm, it would strongly suggest that the previous post
exposure COHb measurements were not an aberration. As planned for rats to 3000 ppm
CO in air for 90 minutes. All 4 rats survived, remained conscious and exhibited no signs of
lethargy when removed from the exposure chamber. The rats attained a COHb level of
approximately 51.6 % (n=1). We then measured the COHb in the remaining three rats at 60
minute time intervals. The results mirrored those observed after an exposure to 1000 ppm
CO (see results figure). By three hours post exposure, the COHb level had returned to base
levels (exposed = 1.9%; control = 1.7%). The data strongly suggests that rate of elimination
of COHb appeared to be independent of CO concentration and exposure time.
The final pilot exposure at 3000 ppm CO continued until the animals reached syncope. This
specific end point was never attained at any point during all of the1000 ppm CO exposure.
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At the 135 minute time point one of the rats had died, and the surviving two began to seize.
The exposure was stopped at 135 minutes. The two surviving rats never reached true
syncope, but were very lethargic when removed from the exposure chamber. They were not
responsive to toe pinch, thus anesthesia was not required prior to heart stick. The rats
attained an average COHb level of 55.4% (n=2) with one of the animals attaining 57.6%.
The original endpoint of COHb > 55% had finally been acheivd. Although syncope
remained elusive, and exposure time of 135 minutes was set as the exposure time for the
3000 ppm CO exposure.
DNS Rat Model Development at 3000 ppm CO
Sixteen rats were exposed to 3000 ppm CO in air for 135 minutes. During the exposure,
four rats died in chamber with 7-10 minutes exposure remaining. This was regarded as
significant, because no rats had died in the exposure chambers. Of the surviving rats several
were appeared disoriented when removed. All rats were lethargic when removed from the
exposure chamber. Two of the surviving rats were very lethargic when removed from the
exposure chamber, and their survival was in question. The CO exposed rats were observed
very closely for 1 hour post exposure. After 24 hours all surviving rats exhibited no futher
signs of lethargy.
Blood samples from the four deceased rats established an upper threshold value past which
the rats would not recover. The average COHb from the deceased animals was 71.8%.
During this exposure rats the time between syncope and death was extremely short, too
short to stop the exposure, evacuate the CO, and the remove them. Basically, if the rats
reached syncope, they died.
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At 24 hours post exposure we performed the Open Field tests on the control and CO
exposed animals, as previously described. Unlike the 24 hour point for the 1000 ppm
exposure there was a noticeable difference in activity levels between the control and Co
exposed rats. This “performance gap” continued to widen, becoming statistically significant
on day 7 post exposure, and reaching a zenith on day 14 post exposure. By day 28 post
exposure, the gap in performance had become statistically insignificant, and was narrower
than the gap at the 24 hour testing point. The data were established as the model for DNS,
as the observed pattern established followed the classic description of DNS: starting small,
becoming more severe, and then going away.
Based on these results, the master plan of the experiment was modified in two key ways: 1)
the neurobehavioral testing would end at 14 days post CO exposure and/or treatment, and
2) the delay in treatment would be set at 4 hours post CO exposure in order to harvest and
analyze the brains of the rats during DNS. At four hours post exposure, the rats would have
completely eliminated any excess COHb caused by exogenous CO; any further delay would
be superfluous. The original philosophy behind the experiment was to mimic in an animal
model what was usually seen in case of CO intoxication in an ER. Our estimate was that by
the time CO intoxication had been verified in a human patient, one at least one COHb halflife had occurred.
Incident at 3000 ppm CO in Air
During the 3000 ppm exposure that was to precede treatment in the hyperbaric chamber an
unforeseen incident occurred. Between 5-10 minutes after reaching 3000 ppm CO in the
exposure the first rat died. This was unusual, because a rat had not died in the exposure
chamber that quickly before. A 25% mortality rate was expected, however, so there was no
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concern. The second and third rats died at 75 minutes into the exposure. This was what
was observed during the optimization trials of the 3000 ppm exposure. Again, this was not a
cause for concern, there were still 60 minutes remaining in the exposure and the rats had
been extremely tolerant of the CO in all the past exposures. Within the next 5 minutes 6
animals died without warning, leaving only 5 surviving rats. Four of the remaining rats died
within the next 20 minutes. The last remaining rat died at the 2 hour point, fifteen minutes
before any of them should have. As mentioned before, the rats had been extremely tolerant
of the CO up this point. This was quite the dilemma. A major exposure/treatment group
had just been lost and fifty rats were waiting for CO exposure over the two days. All
equipment was rechecked, and all equipment checked out. Everything was functioning as it
should be. Euthanizing the remaining rats was an option of last resort, and there was no
longer adequate time to start over. The only endpoint from the exposure optimization study
that would still apply to the reaming rats was the 25% mortality rate. Given all the data we
had accumulated to this point, we divided the remaining rats into three groups of 16 as
originally designated, room air, HBOT, and NBOT (6 control and 10 exposed). The rats
would be exposed to 3000 ppm CO in air. The exposure would continue until 2 rats died
(25% mortality). This way statistical power, would be retained, the experiment would
continue on schedule, and 49 rats would not be needlessly euthanized. The time point
determined by this first exposure would be the exposure time for all remaining exposures in
the experiment. After the first exposure the exposure time was determined to be 80
minutes. It was also decided that three rats from the next lot would be exposed to 3000
ppm of CO for 80 minutes to ensure that they would be able to survive.
Nothing in the literature, or observations of previous exposures had prepared us for this.
Exposures for 135 minutes at 3000 ppm CO had been twice repeated with only a 25%
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mortality. It was hypothesized that the cause of this discrepancy in CO tolerance was the
out breeding of the rats. The rats in this lot of animals lacked genetically what the previous
lot had. This was the only explanation, as the rats were the only thing that was different
during this exposure. There was also concern that the animals would not be exposed to the
CO long enough to produce DNS. This was a valid concern. The exposure at 1000 ppm
for 180 minutes did produce DNS, and given the rapid rate at which the rats eliminate
COHb from their blood anything shorter than a 135 minute exposure would not be
sufficient to reproduce the results seen in the 3000 ppm exposure. A repeatable end point
was required to keep conditions equal for the neurobehavioral tests. The adjustment in
exposure time was not without risks. Comparing the neurobehavioral results to the results
garnered from the development of the DNS model would be tenuous at best since the times
spent in the exposure chamber would differ, and environmental factors would be unequal.
The next 3000 ppm CO exposure lasted for 75 minutes. At that time point 2 rats had died,
and the exposure was ended as previously determined. The deceased rats were removed
from the cages and the surviving rats were placed into the hyperbaric chamber. The
surviving rats were conscious, though lethargic when removed from the placed into the
hyperbaric chamber for treatment. This exposure time was repeated for the next two
exposures in the immediate treatment group. Two rats died at the end of the two exposures
remaining in the immediate treatment group at the 75 minute time point.
Three rats of the next lot were exposed to 3000 ppm CO for 75 minutes. One rat died 4
minutes 25 seconds into the “ramp-up” period of the exposure where the CO level was
approximate 1000 ppm. If this lot of rats (n=64) was hyper sensitive to CO, then the entire
study was in jeopardy. One of the main goals of this study was to establish a treatment
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“window”, we needed the 75 minute exposure to compare the results from the immediate
treatment groups. Fortunately the two remaining rats survived to the end of the 75 minute
exposure. These two “sentinel” rats were lethargic (slow response to toe pinch) at the end
of the exposure. They were observed for 1 hour post exposure and survived, all of the data
we had about the CO exposed rats thus far indicated that if the rats survived the exposure
they would recover, and live through the end of the neurobehavioral tests. After one hour
of close observation, the CO exposed, surviving rats were euthanized per the protocol. In
hindsight this was short sighted. Given the past inconsistencies with the rats a recovery of
24 hours would have been more prudent.
Fortunately, CO hypersensitivity was not an issue for this lot of rats. There was only one
death, over the next three CO exposures (Room Air, HBOT, and NBOT subgroups). The
one mortality occurred 70 minutes into the exposure indicating that these rats were perhaps
similar in their sensitivity to CO. On the other hand, 83% less mortalities also indicates that
perhaps these rats would have been more tolerant of the CO, and survived a longer
exposure. Unfortunately, the neurobehavioral data from this group (delayed treatment) was
to be compared to the previous groups (immediate treatment) so all environmental
conditions were kept the same.
As mentioned above, all but one of the rats in this group survived the CO exposure. After a
four hour delay (during which the rats were removed to their cages with food and water ad
libitum) all rats spent equal time in the hyperbaric chamber (2 hours total), and then returned
to their cages, observed for 1 hour and returned to the vivarium. All the exposed rats
appeared to have returned to normal activity during the four hour delay before treatment.
Given previous data their COHb levels should have returned to background levels by that
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time point. All animals (both control and CO exposed) were alert and active when removed
from the treatment chamber. This was the case regardless of treatment type (room air,
HBOT, or NBOT). This was not surprising as the same results were seen in the immediate
treatment group. This result also lead to fears that the neurological tests for this group
would not yield the same results we had obtained when we developed the neurobehavioral
model for DNS.
Neurobehavioral Testing
As expected (feared) the neurobehavioral test results for both groups (immediate treatment
and delayed treatment) did not yield any statistically significant (p<0.05) neurobehavioral
differences from control rats in all subcategories regardless of treatment. Statistical analyses
between treatment subgroups and across groups (i.e. immediate HBOT vs. delayed HBOT)
yielded nothing. In fact the results for all treatment subgroups resembled the
neurobehavioral results obtained from the 1000 ppm CO exposure. Most telling was that
there were no differences in the measured behaviors between the rats allowed to recover in
room air versus those with either oxygen treatment. The most plausible reason for this is
the reduced CO exposure time in combination with the Sprague-Dawley rat’s demonstrated
ability to eliminate COHb, and the ability for this rat strain to function with 50% of their
blood oxygen carrying capacity comprimised.
An equally plausible explanation for our lack of repeatable results is that we were simply
measuring the wrong behaviors. CO intoxication is well known to affect both learning and
memory (Piantadosi, Zhang et al. 1997). The simple Open field tests do not measure either
of those endpoints
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TUNEL
As expected form the negative neurobehavioral results, no signs of apoptosis occurring “in
process” were detected in the basal ganglia, cortex, or hippocampus in any of the rats, either
CO exposed or control. This was true regardless of exposure or time of death. When
compare to a positive control, the tissue slices showed no apoptotic activity whatsoever. We
did not encounter any false positives as is sometimes encountered with TUNEL assays in
lipid rich tissue (Whiteside, Cougnon et al. 1998; Whiteside and Munglani 1998; Ribble,
Goldstein et al. 2005). The kits were functioning correctly as the positive controls correctly
label damaged DNA (See Results Pictures 4 – 9).
H&E
The brain tissue samples from CO exposed rats also show no signs of necrosis when
compared to control. The tissue itself displayed evidence of post mortem damage done by
cryotome slicing and tissue preparation. Again this result was not surprising as the exposed
rats did not exhibit any neurobehavioral deficits when compared to control or between
exposure and/or treatment groups (See Results Pictures 10 – 15).
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CONCLUSIONS
No measurable evidence of CO induced DNS was not produced in any of the experimental
rats at the 14 day post Co exposure time point, thus the hypotheses put forth cannot be
proven or disproven by this data.
Time of Sacrifice
Although we had previously measured peak neurobehavioral differences between control
and CO exposed rats at 14 days post exposure, given the mercurial nature of DNS, it is
entirely possible that the rats were sacrificed too early. DNS in humans can appear
anywhere from 1 to 6 weeks post CO exposure (Garland and Pearce 1967; Lee and Marsden
1994; White 2008). By shortening the observation period to 14 days, it is entirely possible.
The two lots of rats used for Phase III were clearly different from the lot on which the
model used was based (see Results). It is logical to assume that the rats would develop
neurobehavioral deficits at a different time point. Perhaps waiting for the clinical signs of
DNS to appear (if at all) and sacrificing individual animals at individual time points would
prove a better approach.
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Perhaps a Biochemical Trigger
A recent publication suggests that Xanthine oxidoreductase (XOR) activity is responsible, at
least in part, for CO induced DNS (Han, Bhopale et al. 2007). This would rule out
increased apoptosis or necrosis the cause of CO induced DNS as we hypothesized. The
critical element would be examining the correct pathway at the time the DNS were
occurring.
Different Animal Model
Although our results show a wide variability in CO tolerance in the Sprague-Dawley rat (as
one sees in humans), the study demonstrated that this particular rat strain can eliminate
COHb very rapidly, roughly one sixth the time it take in a human (Haldane 1895; Haldane
1895; Pace, Strajman et al. 1950; Allen and Root 1957; Peterson and Stewart 1970; Sasaki
1975). If this rat strain is doing in room air what it takes a human an hour in 3 atmospheres
of 100% oxygen, then this strain should not be used as model for CO induced DNS. Or, in
order to mimic the clinical situation more accurately, treat the rats at a timepoint that reflects
the same number of half lives of COHb in the rat as would be the case clinically. Although a
neurobehavioral deficit was achieved in CO exposed rats, the result was not repeatable. The
effects of the CO we observed may not have been DNS. There was no real period of
recovery, just a widening behavioral deficit that receded over time. This model is more in
sync with the lingering post exposure effects of CO, rather than true DNS as observed in
humans (Choi 1983; Myers, Snyder et al. 1985; Lee and Marsden 1994; Choi, Kim et al. 1995;
Thom, Taber et al. 1995; Mimura, Harada et al. 1999; Lee, Mak et al. 2001; Gilmer, Kilkenny
et al. 2002; Han, Bhopale et al. 2007; Weaver, Valentine et al. 2007). Also these rats would
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die when they achieved syncope. This being said, perhaps an animal with CO sensitivity
similar to a human, a more terrestrial animal such as a guinea pig, should be used.
Different NB Testing
Due to time a personnel constraints, we chose more simplistic neurobehavioral tests. This
was perhaps short sited as previous studies were able to measure deficits in CO exposed rats
using more robust test such as the radial arm maze (Piantadosi, Zhang et al. 1997; Gorisch
and Schwarting 2006; Han, Bhopale et al. 2007). This testing method measure both learning
and memory, two behavioral deficits that are most like seen in human victims of acute CO
intoxication (Garland and Pearce 1967; Lapresle and Fardeau 1967; Choi 1983; Ginsberg
1985; Benignus 1994).
Change CO Exposure
Our exposure methods were unique from what has been done, in that the exposure was held
constant over time. Other studies involving CO induced DNS use variable Co
concentrations followed by a bolus dose of pure CO to achieve syncope in the rats
(Benignus and Annau 1994; Piantadosi, Zhang et al. 1997; Han, Bhopale et al. 2007). Our
results are consistent with previous observations that syncope is a strong indicator of DNS
development (Choi 1983; Lee and Marsden 1994; Thom, Taber et al. 1995; Prockop and
Chichkova 2007; Weaver, Valentine et al. 2007; White 2008). The rats did not achieve
syncope as a result of our chosen exposure method (see methods), thus it was unlikely the
rats would develop DNS as planned.
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